People's United Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.23M | Sell |
1,757
-1,236
| -41% | -$863K | 0.03% | 301 |
|
|
2021
Q4 | $1.89M | Buy |
2,993
+2,503
| +511% | +$1.58M | 0.05% | 241 |
|
|
2021
Q3 | $297K | Buy |
490
+3
| +0.6% | +$1.82K | 0.01% | 614 |
|
|
2021
Q2 | $272K | Sell |
487
-90
| -16% | -$50.3K | 0.01% | 635 |
|
|
2021
Q1 | $273K | Sell |
577
-157
| -21% | -$74.3K | 0.01% | 609 |
|
|
2020
Q4 | $355K | Sell |
734
-177
| -19% | -$85.6K | 0.01% | 532 |
|
|
2020
Q3 | $510K | Sell |
911
-51
| -5% | -$28.6K | 0.01% | 426 |
|
|
2020
Q2 | $600K | Buy |
962
+230
| +31% | +$143K | 0.02% | 384 |
|
|
2020
Q1 | $357K | Buy |
+732
| New | +$357K | 0.01% | 439 |
|
|
2019
Q2 | – | Sell |
-700
| Closed | -$288K | – | 786 |
|
|
2019
Q1 | $288K | Buy |
700
+85
| +14% | +$35K | 0.01% | 616 |
|
|
2018
Q4 | $230K | Sell |
615
-26
| -4% | -$9.72K | 0.01% | 661 |
|
|
2018
Q3 | $259K | Buy |
+641
| New | +$259K | 0.01% | 637 |
|
|
2017
Q3 | – | Sell |
-454
| Closed | -$223K | – | 830 |
|
|
2017
Q2 | $223K | Buy |
454
+394
| +657% | +$194K | 0.01% | 600 |
|
|
2017
Q1 | $23K | Hold |
60
| – | – | ﹤0.01% | 804 |
|
|
2016
Q4 | $22K | Sell |
60
-40
| -40% | -$14.7K | ﹤0.01% | 785 |
|
|
2016
Q3 | $40K | Hold |
100
| – | – | ﹤0.01% | 598 |
|
|
2016
Q2 | $35K | Sell |
100
-25
| -20% | -$8.75K | ﹤0.01% | 604 |
|
|
2016
Q1 | $45K | Hold |
125
| – | – | ﹤0.01% | 574 |
|
|
2015
Q4 | $68K | Buy |
125
+25
| +25% | +$13.6K | ﹤0.01% | 544 |
|
|
2015
Q3 | $47K | Buy |
+100
| New | +$47K | ﹤0.01% | 572 |
|